drug makers
Deals between brand-name drugmakers and their generic drug competitors that keep cheaper products off the market might illegally prevent competition, the U.S. Supreme Court ruled June 17.
If you owned the bestselling prescription drug of all time and its patent was about to expire, how would you prepare for competition from generic drugs?